We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
8.08%
Top 10 Hldgs %
37.79%
Holding
268
New
72
Increased
34
Reduced
55
Closed
76

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.3M
2
SONX
Sonendo, Inc.
SONX
+$7.34M
3
NTRA icon
Natera
NTRA
+$6.8M
4
AZTA icon
Azenta
AZTA
+$6.45M
5
QTRX icon
Quanterix
QTRX
+$5.89M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$22.4M
2
ILMN icon
Illumina
ILMN
+$11.7M
3
AZN icon
AstraZeneca
AZN
+$9.6M
4
OM icon
Outset Medical
OM
+$8.46M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 27.35%
2 Industrials 0.25%
3 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICUI icon
26
CALL
ICU Medical
ICUI
$4.47B
$18.9M 0.98%
120,000
-5,000
-4% -$761K
BIIB icon
27
Biogen
BIIB
$30.2B
$17.4M 0.9%
62,720
+57,720
+1,154% +$16.3M
DHR icon
28
PUT
Danaher
DHR
$144B
$17.3M 0.89%
+73,320
New +$17M
LIVN icon
29
CALL
LivaNova
LIVN
$4.41B
$16.7M 0.86%
301,000
-379,100
-56% -$19.4M
VRAY
30
CALL
DELISTED
ViewRay, Inc.
VRAY
$16.6M 0.86%
3,700,000
+1,200,000
+48% +$5.22M
DENT
31
CALL
DELISTED
AdvisorShares Dent Tactical ETF
DENT
$15.7M 0.81%
2,250,000
-4,700
-0.2% -$32.9K
ALNY icon
32
CALL
Alnylam Pharmaceuticals
ALNY
$29.9B
$15.5M 0.8%
+65,400
New +$13.9M
QTRX icon
33
CALL
Quanterix
QTRX
$121M
$15.3M 0.79%
1,105,800
+605,800
+121% +$6.97M
SONX
34
DELISTED
Sonendo, Inc.
SONX
$13.9M 0.72%
4,916,045
+3,892,621
+380% +$7.34M
EXAS
35
CALL
DELISTED
Exact Sciences
EXAS
$13.6M 0.7%
275,000
-100,000
-27% -$4.09M
LIVN icon
36
LivaNova
LIVN
$4.41B
$12.7M 0.65%
227,951
-15,138
-6% -$773K
OLK
37
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$12.4M 0.64%
490,127
-129,596
-21% -$2.61M
OM icon
38
Outset Medical
OM
$88.3M
$11.7M 0.61%
30,293
-30,015
-50% -$8.46M
ILMN icon
39
CALL
Illumina
ILMN
$28.7B
$11.6M 0.6%
59,110
-28,270
-32% -$5.86M
GH icon
40
Guardant Health
GH
$22.3B
$11.6M 0.6%
426,874
+25,890
+6% +$1.18M
IART icon
41
PUT
Integra LifeSciences
IART
$1.33B
$11.3M 0.58%
+201,500
New +$10.3M
CYTK icon
42
Cytokinetics
CYTK
$10.7B
– –
-15,000
Closed -$645K
HSIC icon
43
PUT
Henry Schein
HSIC
$9.97B
$11.2M 0.58%
+140,000
New +$10.6M
GH icon
44
CALL
Guardant Health
GH
$22.3B
$11.1M 0.57%
408,900
-161,100
-28% -$7.37M
GKOS icon
45
CALL
Glaukos
GKOS
$10.7B
$10.9M 0.56%
250,000
-360,000
-59% -$17.8M
CUTR
46
CALL
DELISTED
Cutera, Inc.
CUTR
$10.7M 0.55%
242,500
+142,500
+143% +$6.5M
MDGL icon
47
PUT
Madrigal Pharmaceuticals
MDGL
$12.4B
$10.4M 0.54%
+36,000
New +$3.52M
APLS
48
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$10.3M 0.53%
200,000
– –
ELV icon
49
PUT
Elevance Health
ELV
$84.9B
$10.3M 0.53%
20,000
-15,000
-43% -$7.62M
NSTG
50
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
$10.3M 0.53%
1,286,300
-103,700
-7% -$899K
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Pura Vida Investments held 268 positions worth $1.94B, up 12% from $1.73B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments deployed $157M of net new capital in Q4 2022, opening 72 new positions and adding to 34 existing holdings. Its largest new stake was Natera: 165,000 shares worth $6.63M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 35% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was United Therapeutics, an estimated $22.4M trimmed.

  • Pura Vida Investments's largest Q4 2022 buy was Natera: 165,000 shares worth $6.63M.
  • Pura Vida Investments added most to Biogen in Q4 2022, an estimated $16.3M increase.
  • Pura Vida Investments's biggest Q4 2022 reduction was United Therapeutics, cutting an estimated $22.4M.
  • Pura Vida Investments fully exited Illumina in Q4 2022, selling an estimated $11.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $1.94B portfolio in Q4 2022.
  • Pura Vida Investments opened 72 new positions and closed 76 in Q4 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.